AcelRx Pharmaceuticals CEO and leadership

• Pharmaceutical/Biotech executive with over 23 years’ experience in successful commercialization (sales, marketing, trade, managed markets, training and development, market research, sales operations, supply chain), general operations (IT, facilities), business development, leadership development, investor relations and strategic planning.

• Proven track record of commercialization success in diverse business structures including large public pharma, start-up specialty private pharma and public biotech inclusive of building and scaling commercial operations to the needs of the organization.

• Accomplishments include launching a blockbuster mass market brand/category, re-launching specialty and mass market brands to generate positive brand P&Ls, and corporate M&A leading to the exit of a specialty pharma company for $1.65B.

Pamela Pierce Palmer has dedicated her career to researching and treating pain, first as an anesthesiologist at UCSF and in her current role as chief medical officer at AcelRx, a company she co-founded in July 2005.

Badri Dasu is a Chief Engineering Officer at ACELRX PHARMACEUTICALS INC. He has worked as VP:MFG & Device Development at Powderject Technologies Inc, VP:MFG & Process Devpt at Powderject Pharmaceuticals, and VP:Medical Device Enginrg at Anesiva Inc. Badri works or has worked at Metrika and Cygnus Inc and works or has worked as MEMBER at American Institute of Chemical Engineers and MEMBER at American Association of Medical Instrumentation. He attended University of Tulsa/The and Mangalore University.

A strategic and operational senior finance executive with international leadership experience and proven success in leading and implementing change in public and private equity sponsored companies. Proven leader of multinational finance organizations, including M&A, investor relations and procurement.

Pamela Pierce Palmer has dedicated her career to researching and treating pain, first as an anesthesiologist at UCSF and in her current role as chief medical officer at AcelRx, a company she co-founded in July 2005.

• Pharmaceutical/Biotech executive with over 23 years’ experience in successful commercialization (sales, marketing, trade, managed markets, training and development, market research, sales operations, supply chain), general operations (IT, facilities), business development, leadership development, investor relations and strategic planning.

• Proven track record of commercialization success in diverse business structures including large public pharma, start-up specialty private pharma and public biotech inclusive of building and scaling commercial operations to the needs of the organization.

• Accomplishments include launching a blockbuster mass market brand/category, re-launching specialty and mass market brands to generate positive brand P&Ls, and corporate M&A leading to the exit of a specialty pharma company for $1.65B.

Pamela Pierce Palmer has dedicated her career to researching and treating pain, first as an anesthesiologist at UCSF and in her current role as chief medical officer at AcelRx, a company she co-founded in July 2005.